Effects of neonatal exposure to methamphetamine: Catecholamine levels in brain areas of the developing rat

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 602-611

  Gomes Da Silva, Joana ^a   De Miguel, Rosario ^b   Fernández Ruiz, Javier ^b   Summavielle, Teresa ^a,c   Tavares, M Amélia ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c All Health Sciences School of Porto   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Dopamine; Dopaminergic areas; Gender; Methamphetamine; Neonatal; Norepinephrine; Rat; Wistar rat

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOPAMINE; METHAMPHETAMINE; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CATECHOLAMINE BRAIN LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONTOGENY; PERINATAL DRUG EXPOSURE; PREFRONTAL CORTEX; PUTAMEN; RAT; SEX DIFFERENCE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALIA; RATTUS NORVEGICUS;

EID: 10444268132     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.075     Document Type: Conference Paper

References (35)

1. BRUNSWICK, D.J. et al. 1992. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11: 287-293.
2. WANG, Y. et al. 2000. Chronic methamphetamine exposure decreases high affinity uptake function in norepinephrine afferents in the cerebellar cortex: an electrophysiological and electrochemical study. Neuropharmacology 39: 2112-2123.
3. LAUDER, J.M. & F.E. BLOOM. 1974. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J. Comp. Neurol. 155:469-481.
4. VOORN, P. et al. 1988. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25: 857-887.
5. TEPPER, J.M., M. DAMLAMA & F. TRENT. 1994. Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 60: 469-477.
6. TRULSON, M.E. et al. 1985. Effects of chronic methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies. Brain Res. Bull. 15: 569-577.
7. TRULSON, M.E. et al. 1987. Tyrosine hydroxylase immunochemistry and quantitative light microscopic studies of the mesolimbic dopamine system in rat brain: effects of chronic methamphetamine administration. Brain Res. Bull. 18: 269-277.
8. HARVEY, D.C. et al. 2000. Recovery from methamphetamine-induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res. 871: 259-270.
9. ZHANG, Y. et al. 2001. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N.Y. Acad. Sci. 937: 93-120.
10. BAYER, S.A. et al. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14: 83-144.
11. FALLON, J.H. & S.E. LOUGHLIN. 1995. Substantia nigra. In The Rat Nervous System. G. Paxinos & J. Watson, Eds.: 215-237. Academic Press. Sydney.
12. KOOB, G.F. 1998. Circuits, drugs, and drug addiction. Adv. Pharmacol. 42: 978-982.
13. BONNIN, A. et al. 1994. Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Dev. Brain Res. 81: 147-150.
14. LOWRY, O.K. et al. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
15. WAGNER, G.C., T.L. TEKIRIAN & C.T. CHEO. 1993. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. Gen. Sect. 93: 67-70.
16. HIRATA, H. et al. 1996. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714: 95-103.
17. MILLER, D.B. et al 1998. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. N.Y. Acad. Sci. 844: 153-165.
18. GOMES-DA-SILVA, J., M.C. SILVA & M.A. TAVARES. 1998. Developmental exposure to methamphetamine: a neonatal model in the rat. Ann. N.Y. Acad. Sci. 844: 310-313.
19. GOMES-DA-SILVA, J. et al. 2000. Neonatal methamphetamine in the rat: evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system. Ann. N.Y. Acad. Sci. 914: 431-438.
20. PU, C. & C.V. VORHEES. 1993. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Dev. Brain Res. 72: 325-328.
21. CAPPON, G.D., L.L. MORFORD & C.V. VORHEES. 1997. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Dev. Brain Res. 103: 155-162.
22. KOKOSHKA, J.M. et al. 2000. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J. Neurochem. 75: 2095-2102.
23. O'CALLAGHAN, J.P. & D.B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 741-751.
24. BOLANOS, C.A., S.J. GLATT & D. JACKSON. 1998. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Dev. Brain Res. 111: 25-33.
25. SHISHIDO, T. et al. 1997. Acute methamphetamine administration increases tyrosine hydroxylase mRNA levels in the rat locus coeruleus. Mol. Brain Res. 52: 146-150.
26. ROTHMAN, R.B. et al. 2001. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41.
27. ASTON-JONES, G., M.T. SHIPLEY & R. GRZANNA. 1995. The locus coeruleus, A5 and A7 noradrenergic cell groups. In The Rat Nervous System. G. Paxinos & J. Watson, Eds.: 183-213. Academic Press. Sydney.
28. LUCOT, J.B. et al. 1982. Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine. Brain Res. 247: 181-183.
29. FORNAI, F. et al. 1996. Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats. Brain Res. 735: 349-353.
30. FORNAI, F. et al. 1998. Noradrenergic modulation of methamphetamine- induced striatal dopamine depletion. Ann. N.Y. Acad. Sci. 844: 166-177.
31. TSUCHIDA, K. et al. 1996. Ontogeny of striatal dopamine release in rats after acute administration of methamphetamine. Pharmacol. Biochem. Behav. 53: 575-580.
32. SELF, D.W. & E.J. NESTLER. 1995. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18: 463-495.
33. BERKE, J.D. & S.E. HYMAN. 2000. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515-532.
34. ZUCH, C.L. et al. 2000. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J. Comp. Neurol. 427: 440-454.
35. KALIVAS, P.W. & P. DUFFY. 1993. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J. Neurosci. 13: 276-284.